首页|幽门螺杆菌阳性慢性胃炎患者采用益生菌联合铋剂四联治疗的临床效果

幽门螺杆菌阳性慢性胃炎患者采用益生菌联合铋剂四联治疗的临床效果

扫码查看
目的 探析幽门螺杆菌(Hp)阳性慢性胃炎患者应用铋剂四联治疗联合益生菌治疗的临床效果.方法 80 例Hp阳性慢性胃炎患者,按照用药方式不同分为观察组和对照组,每组 40 例.观察组给予益生菌联合铋剂四联治疗方案,对照组单用铋剂四联治疗方案.对比两组临床疗效,Hp根除率,不良反应发生率,治疗前后各症状评分及胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)、胃泌素(GS)变化情况.结果 治疗 2 周后,两组上腹疼痛、反酸嗳气、恶心呕吐评分均降低,且观察组上腹疼痛、反酸嗳气、恶心呕吐评分分别为(0.72±0.64)、(0.36±0.29)、(0.52±0.40)分,低于对照组的(1.09±0.70)、(0.98±0.79)、(1.03±0.94)分(P<0.05).观察组的临床总有效率(97.50%)高于对照组(82.50%)(P<0.05).观察组的Hp根除率(100.00%)高于对照组(87.50%)(P<0.05).治疗 2 周后,两组的PGⅠ、PGⅡ、GS均降低,且观察组PGⅠ(74.11±13.24)μg/L、PGⅡ(4.92±1.79)μg/L、GS(63.26±6.02)pg/ml低于对照组的(101.56±16.33)μg/L、(9.36±2.31)μg/L、(79.33±6.47)pg/ml(P<0.05).观察组的不良反应总发生率(10.00%)低于对照组(30.00%)(P<0.05).结论 Hp阳性慢性胃炎患者实施益生菌联合铋剂四联治疗,可改善其临床症状,Hp根除率较高,且不良反应风险小,效果较佳.
Clinical effect of probiotics combined with bismuth-containing quadruple treatment for patients with Helicobacter pylori positive chronic gastritis
Objective To explore the clinical effect of probiotics combined with bismuth-containing quadruple treatment for patients with Helicobacter pylori(Hp)positive chronic gastritis.Methods 80 patients with Hp positive chronic gastritis were divided into an observation group and a control group according to different treatment methods,with 40 cases in each group.The observation group received probiotics and bismuth-containing quadruple treatment,and the control group received bismuth-containing quadruple treatment alone.The clinical efficacy,Hp eradication rate,incidence of adverse reactions,symptom scores and the changes of pepsinogenⅠ(PGⅠ),pepsinogenⅡ(PGⅡ)and gastrin(GS)before and after treatment were compared between the two groups.Results After 2 weeks of treatment,the scores of upper abdominal pain,belching and acid reflux,nausea and vomiting were decreased in both groups;the scores of upper abdominal pain,belching and acid reflux,nausea and vomiting in the observation group were(0.72±0.64),(0.36±0.29)and(0.52±0.40)points,which were lower than(1.09±0.70),(0.98±0.79)and(1.03±0.94)points in the control group(P<0.05).The total clinical effective rate of the observation group(97.50%)was higher than that of the control group(82.50%)(P<0.05).The Hp eradication rate in the observation group(100.00%)was higher than that in the control group(87.50%)(P<0.05).After 2 weeks of treatment,the PGⅠ,PGⅡ and GS were decreased in both groups;the observation group had PGⅠ of(74.11±13.24)μg/L,PGⅡ of(4.92±1.79)μg/L and GS of(63.26±6.02)pg/ml,which were lower than(101.56±16.33)μg/L,(9.36±2.31)μg/L and(79.33±6.47)pg/m in the control group(P<0.05).The total incidence of adverse reactions in the observation group(10.00%)was lower than that in the control group(30.00%)(P<0.05).Conclusion Probiotics combined with bismuth-containing quadruple treatment has significant effect on for patients with Hp positive chronic gastritis,and can improve the clinical symptoms of patients.The eradication rate of HP is high and the risk of adverse reactions is low.

Helicobacter pyloriChronic gastritisBismuth-containing quadruple treatmentProbioticsEradication rateAdverse reactions

徐建

展开 >

276400 临沂市中心医院

幽门螺杆菌 慢性胃炎 铋剂四联 益生菌 根除率 不良反应

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(4)
  • 26